You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

List of Excipients in API betaxolol


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing betaxolol

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Novartis Pharmaceuticals Corporation BETOPTIC S betaxolol hydrochloride 0078-0729 BENZALKONIUM CHLORIDE
Novartis Pharmaceuticals Corporation BETOPTIC S betaxolol hydrochloride 0078-0729 EDETATE DISODIUM
Novartis Pharmaceuticals Corporation BETOPTIC S betaxolol hydrochloride 0078-0729 HYDROCHLORIC ACID
Novartis Pharmaceuticals Corporation BETOPTIC S betaxolol hydrochloride 0078-0729 MANNITOL
Novartis Pharmaceuticals Corporation BETOPTIC S betaxolol hydrochloride 0078-0729 SODIUM HYDROXIDE
Novartis Pharmaceuticals Corporation BETOPTIC S betaxolol hydrochloride 0078-0729 WATER
Sandoz Inc BETAXOLOL HYDROCHLORIDE betaxolol hydrochloride 61314-245 BENZALKONIUM CHLORIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing betaxolol

Company Ingredient NDC Excipient
Marlex Pharmaceuticals Inc betaxolol 10135-623 ANHYDROUS LACTOSE
Marlex Pharmaceuticals Inc betaxolol 10135-623 CARNAUBA WAX
Marlex Pharmaceuticals Inc betaxolol 10135-623 CELLULOSE, MICROCRYSTALLINE
Marlex Pharmaceuticals Inc betaxolol 10135-623 HYPROMELLOSE 2208
Marlex Pharmaceuticals Inc betaxolol 10135-623 POLYETHYLENE GLYCOLS
Marlex Pharmaceuticals Inc betaxolol 10135-623 POLYSORBATE 80
Marlex Pharmaceuticals Inc betaxolol 10135-623 SODIUM STARCH GLYCOLATE TYPE A POTATO
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for betaxolol

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: EDETATE DISODIUM

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: MANNITOL

Excipient focus: POLYETHYLENE GLYCOL

betaxolol drug variants not containing POLYETHYLENE GLYCOL

Company Ingredient NDC
Marlex Pharmaceuticals Inc betaxolol 10135-623
Physicians Total Care Inc betaxolol 54868-4932
Golden State Medical Supply Inc betaxolol 60429-753
Novartis Pharmaceuticals Corporation betaxolol hydrochloride 0078-0729
KVK-TECH INC betaxolol hydrochloride 10702-013
Akorn betaxolol hydrochloride 17478-705
Sandoz Inc betaxolol hydrochloride 61314-245
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYETHYLENE GLYCOL 400

betaxolol drug variants not containing POLYETHYLENE GLYCOL 400

Company Ingredient NDC
Marlex Pharmaceuticals Inc betaxolol 10135-623
PuraCap Laboratories LLC betaxolol 24658-700
Epic Pharma LLC betaxolol 42806-038
Physicians Total Care Inc betaxolol 54868-4932
Novartis Pharmaceuticals Corporation betaxolol hydrochloride 0078-0729
Akorn betaxolol hydrochloride 17478-705
Sandoz Inc betaxolol hydrochloride 61314-245
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYETHYLENE GLYCOLS

betaxolol drug variants not containing POLYETHYLENE GLYCOLS

Company Ingredient NDC
PuraCap Laboratories LLC betaxolol 24658-700
Epic Pharma LLC betaxolol 42806-038
Golden State Medical Supply Inc betaxolol 60429-753
Novartis Pharmaceuticals Corporation betaxolol hydrochloride 0078-0729
KVK-TECH INC betaxolol hydrochloride 10702-013
Akorn betaxolol hydrochloride 17478-705
Sandoz Inc betaxolol hydrochloride 61314-245
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYSORBATE 80

Excipient focus: SODIUM CHLORIDE

betaxolol drug variants not containing SODIUM CHLORIDE

Company Ingredient NDC
Marlex Pharmaceuticals Inc betaxolol 10135-623
PuraCap Laboratories LLC betaxolol 24658-700
Epic Pharma LLC betaxolol 42806-038
Physicians Total Care Inc betaxolol 54868-4932
Golden State Medical Supply Inc betaxolol 60429-753
Novartis Pharmaceuticals Corporation betaxolol hydrochloride 0078-0729
KVK-TECH INC betaxolol hydrochloride 10702-013
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links